Dr. Russell Szmulewitz, MD – Chicago, IL

Overview of Dr. Szmulewitz

Dr. Russell Szmulewitz is an oncologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 14 years. Dr. Szmulewitz accepts several types of health insurance, listed below. He is one of 122 doctors at University of Chicago Medical Center who specialize in Oncology. He has more than 80 publications and over 500 citings.

Education & Training

• University of ChicagoFellowship, Hematology and Medical Oncology, 2006 - 2009

• NYU Grossman School of MedicineResidency, Internal Medicine, 2003 - 2006

• University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003

Certifications & Licensure

Awards, Honors, & Recognition

• CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

• The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

  Halabi, S., Guo, S., Park, J., George, D., McDonnell, D., Norris, J., Lu, C., Luo, J., Armstrong, A., Nanus, D., Antonarakis, E., Danila, D., Szmulewitz, R.> ;Clinical Cancer Research. 2024 Jan 18

• Bladder-Preserving Trimodality Therapy With Capecitabine.

  Lynch, C., Stadler, W., O'Donnell, P., Sweis, R., Modi, P., Agarwal, P., Szmulewitz, R., Liauw, S., Pitroda, S.> ;Clinical Genitourinary Cancer. 2024 Jan 9

• Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis.

  Gomez-Veiga, F., Azad, A., Iguchi, T., Villers, A., Alcaraz, A., Alekseev, B., Rosbrook, B., Zohren, F., Ma, J., Haas, G., Stenzl, A., Szmulewitz, R., Holzbeierlein, J...> ;European Urology Oncology. 2023 Dec 9
• Join now to see all

Press Mentions

• Benefits of PSMA-PET for High-risk/Advanced Prostate Cancer: Part 2August 26th, 2022

• Benefits of PSMA-PET for High-risk/Advanced Prostate Cancer: Part 1August 26th, 2022

• Taking a Standard Prostate Cancer Drug with Food Boosts Impact, Lowers CostMarch 30th, 2018

• Join now to see all

Hospital Affiliations

Insurance Accepted

• Aetna Choice POS II
  Aetna HMO
  BCBS Blue Card PPO
  BCBS Illinois PPO
  Cofinity PPO
  Coventry Health Care PPO Platinum
  Coventry Missouri - HMO/POS
  

  First Health PPO
  HealthLink PPO
  Multiplan PHCS PPO
  Multiplan PPO
  Sagamore Health Plus
  United Healthcare - Direct Choice Plus POS
  United Healthcare - Direct Options PPO
  

• Please verify your coverage with the provider's office directly when scheduling an appointment